Insmed (INSM) Non-Current Debt (2012 - 2026)

Insmed (INSM) recorded quarterly Non-Current Debt of $542.2 million in Q1 2026, little changed quarter-over-quarter from $541.0 million in Q4 2025, and down 50.93% on a YoY basis from $1.1 billion in Q1 2025.

Insmed (INSM) Non-Current Debt (2012 - 2026) Analysis & Trends

Insmed's Non-Current Debt history runs 15 years deep, the most recent figure standing at $542.2 million for Q1 2026.

  • In Q1 2026, Non-Current Debt fell 50.93% year-over-year to $542.2 million; the TTM figure through Mar 2026 stood at $542.2 million (down 50.93% YoY), while the FY2025 annual figure was $541.0 million, down 50.97% from the prior year.
  • Non-Current Debt was $542.2 million for Q1 2026 at Insmed, roughly flat from $541.0 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $1.2 billion in Q4 2023 to a low of $538.5 million in Q2 2025.
  • Historically, Non-Current Debt has averaged $897.8 million across 5 years, with a median of $946.8 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Debt jumped 116.6% in 2022, then plunged 50.97% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $1.1 billion in 2022, then climbed by 2.67% to $1.2 billion in 2023, then dropped by 4.49% to $1.1 billion in 2024, then slumped by 50.97% to $541.0 million in 2025, then rose by 0.23% to $542.2 million in 2026.
  • The last three Non-Current Debt figures came in at $542.2 million (Q1 2026), $541.0 million (Q4 2025), and $539.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 319.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Insmed 19.79 Bn 18.57 Bn 258.54 Mn 542.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 542.22 Mn
Mar 31, 2026 542.22 Mn
Dec 31, 2025 540.96 Mn
Dec 31, 2025 540.96 Mn
Sep 30, 2025 539.72 Mn
Sep 30, 2025 539.72 Mn
Jun 30, 2025 538.51 Mn
Jun 30, 2025 538.51 Mn
Mar 31, 2025 1.11 Bn
Mar 31, 2025 1.11 Bn
Dec 31, 2024 1.10 Bn
Dec 31, 2024 1.10 Bn
Sep 30, 2024 954.83 Mn
Sep 30, 2024 954.83 Mn
Jun 30, 2024 946.83 Mn
Jun 30, 2024 946.83 Mn
Mar 31, 2024 939.08 Mn
Mar 31, 2024 939.08 Mn
Dec 31, 2023 1.16 Bn
Dec 31, 2023 1.16 Bn